COYA – coya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Coya Therapeutics (COYA) was upgraded by Wall Street Zen from "sell"
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $15.00 price target on the stock.
Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
ReAlta Life Sciences Appoints Howard Berman, Ph.D., as CEO and Kia Motesharei, Ph.D., as President and COO
Form 4 Coya Therapeutics, Inc. For: Apr 09 Filed by: Pavao Mark H
Form 3 Coya Therapeutics, Inc. For: Apr 01 Filed by: Pavao Mark H
Form 8-K Coya Therapeutics, Inc. For: Mar 29
Form EFFECT Coya Therapeutics, Inc.
Form 424B3 Coya Therapeutics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.